Growth Metrics

Adma Biologics (ADMA) Amortizatization of Intangibles (2016 - 2025)

Adma Biologics' Amortizatization of Intangibles history spans 13 years, with the latest figure at $197000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 10.05% year-over-year to $197000.0; the TTM value through Dec 2025 reached $717000.0, down 24.61%, while the annual FY2025 figure was $717000.0, 24.61% down from the prior year.
  • Amortizatization of Intangibles reached $197000.0 in Q4 2025 per ADMA's latest filing, up from $170000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $981066.0 in Q3 2022 to a low of $160000.0 in Q2 2025.
  • Average Amortizatization of Intangibles over 5 years is $428050.0, with a median of $454075.5 recorded in 2021.
  • Peak YoY movement for Amortizatization of Intangibles: skyrocketed 101.87% in 2022, then tumbled 68.62% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $502858.0 in 2021, then fell by 1.79% to $493873.0 in 2022, then surged by 41.33% to $698000.0 in 2023, then crashed by 68.62% to $219000.0 in 2024, then fell by 10.05% to $197000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Amortizatization of Intangibles are $197000.0 (Q4 2025), $170000.0 (Q3 2025), and $160000.0 (Q2 2025).